Cargando…
Widding the Use of Insulin Sensitizers to Patients with Polycystic Ovarian Syndrome—A Late, but Wise Decision
Autor principal: | Silva de Sá, Marcos Felipe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Publicações Ltda
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316815/ https://www.ncbi.nlm.nih.gov/pubmed/30991430 http://dx.doi.org/10.1055/s-0039-1685482 |
Ejemplares similares
-
New Criteria for the Clinical Diagnosis of Hyperandrogenism in Polycystic Ovarian Syndrome and the Risk of Overdiagnosis
por: Soares-Jr, José Maria, et al.
Publicado: (2019) -
Insulin Resistance in Polycystic Ovarian Syndrome
por: Purwar, Ananya, et al.
Publicado: (2022) -
Post-glucose insulin level in polycystic ovarian syndrome
por: Wiwanitkit, Somsri, et al.
Publicado: (2011) -
Association between polycystic ovarian morphology and insulin resistance in women with polycystic ovary syndrome
por: Lee, Jeong Eun, et al.
Publicado: (2023) -
The Effect of Time-Restricted Eating on Insulin Levels and Insulin Sensitivity in Patients with Polycystic Ovarian Syndrome: A Systematic Review
por: Floyd, R., et al.
Publicado: (2022)